The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases Conference

cited authors

  • Sperduto, Paul W; Yang, T Jonathan; Beal, Kathryn; Pan, Hubert; Brown, Paul D; Bangdiwala, Ananta; Shanley, Ryan; Yeh, Norman; Gaspar, Laurie E; Braunstein, Steve; Gaspar, Laurie E; Braunstein, Steve; Sneed, Penny; Boyle, John; Kirkpatrick, John P; Mak, Kimberley S; Shih, Helen A; Engelman, Alex; Roberge, David; Arvold, Nils D; Alexander, Brian; Awad, Mark M; Contessa, Joseph; Chiang, Veronica; Hardie, John; Ma, Daniel; Lou, Emil; Sperduto, William; Mehta, Minesh P

fiu authors

publication date

  • October 1, 2016

keywords

  • CANCER
  • CHEMOTHERAPY
  • EGFR
  • ERLOTINIB
  • Life Sciences & Biomedicine
  • Oncology
  • RADIATION-THERAPY
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • Radiology, Nuclear Medicine & Medical Imaging
  • SECONDARY ANALYSIS
  • SINGLE METASTASES
  • STEREOTACTIC RADIOSURGERY
  • Science & Technology

Location

  • San Diego, CA

Digital Object Identifier (DOI)

Conference

  • ASTRO Meeting

start page

  • 406

end page

  • 413

volume

  • 96

issue

  • 2